Condition: Crohn's Disease · Sponsor: Takeda
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate medical problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| United Medical Doctors | Murrieta, California, United States | Recruiting |
| UCI Health | Orange, California, United States | Recruiting |
| West Central Gastroenterology, LLP, d/b/a/ Gastro Florida | Clearwater, Florida, United States | Recruiting |
| Auzmer Research | Lakeland, Florida, United States | Recruiting |
| Wellness Clinical Research | Miami Lakes, Florida, United States | Recruiting |
| GI PROS, Inc. | Naples, Florida, United States | Recruiting |
| AdventHealth (Florida Hospital) Medical Group | Orlando, Florida, United States | Not Yet Recruiting |
| USF Health Morsani Center for Advanced Healthcare | Tampa, Florida, United States | Recruiting |
| Emory University Hospital, The Emory Clinic | Atlanta, Georgia, United States | Recruiting |
| Atlanta Center For Gastroenterology, P.C. | Decatur, Georgia, United States | Recruiting |
| The University of Iowa Hospitals & Clinics | Iowa City, Iowa, United States | Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Not Yet Recruiting |
+ 178 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06233461